Yahoo! Finance: Biotechnology Industry News: Ongoing Phase I Monotherapy Study of Rucaparib in Patients with Solid Tumors Demonstrates Clinical Activity, Establishes Dose and Schedule

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

Ongoing Phase I Monotherapy Study of Rucaparib in Patients with Solid Tumors Demonstrates Clinical Activity, Establishes Dose and Schedule Sep 29th 2013, 07:30 [Business Wire] - Clovis Oncology today announced updated results from an ongoing Phase I/II monotherapy study of rucaparib, the Company's oral, potent, small molecule poly polymerase inhibitor being developed for the treatment of ovarian cancer.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions